Shane Prejean

MD

Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL

Articles by Shane Prejean, MD

Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) Inhibition in Patients With or at High Risk of Coronary Heart Disease

Shane Prejean, Todd M Brown,

Citation: US Cardiology Review 2017;11(1):16–7

DOI:

https://doi.org/10.15420/usc.2017:5:2